Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines

Clin Vaccine Immunol. 2007 Aug;14(8):1053-5. doi: 10.1128/CVI.00173-07. Epub 2007 Jun 27.

Abstract

We determined the levels of adenovirus 5 (Ad5) neutralizing antibodies in children in India less than 2 years of age. The results clearly show an age-dependent increase in Ad5-specific immunity, with 7- to 12-month-old children having the lowest levels of Ad5 immunity. This opens up the scope for the use of recombinant Ad5-based vaccines in this age group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenovirus Infections, Human / epidemiology*
  • Adenovirus Infections, Human / immunology
  • Adenovirus Infections, Human / virology
  • Adenoviruses, Human / classification
  • Adenoviruses, Human / genetics
  • Adenoviruses, Human / immunology*
  • Age Factors
  • Antibodies, Viral / blood*
  • Child, Preschool
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • India / epidemiology
  • Infant
  • Infant, Newborn
  • Neutralization Tests
  • Serotyping
  • Vaccines, Synthetic
  • Viral Vaccines

Substances

  • Antibodies, Viral
  • Vaccines, Synthetic
  • Viral Vaccines